In-Home Care for Patients With Parkinson's Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

164 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-05-07

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Advanced Parkinson's Disease is a debilitating, costly, and understudied condition. Improving access to comprehensive, specialized, in-home patient care and caregiver support offers the potential to minimize the downward spiral of morbidity and preventable healthcare utilization. The aim of this study is to test whether and to what degree an interdisciplinary home visit program, with and without peer mentoring for caregivers, will improve patient- and caregiver-reported outcomes and reduce healthcare costs when compared with usual care in advanced Parkinson's Disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Telerehabilitation for Parkinson's Disease

NCT04600011

Parkinson Disease Telemedicine

COMPLETED NA

Bringing Parkinson Care Back Home

NCT04288583

Parkinson Disease

UNKNOWN

Providing Specialty Care to Individuals With Parkinsonism Directly in Their Homes Via Web-based Video Conferencing- A Comparative Effectiveness Study

NCT01476306

Parkinson Disease

COMPLETED NA

Mild Cognitive Impairment and Endurance Exercise in Parkinson's Disease

NCT03542474

Parkinson Disease Mild Cognitive Impairment

COMPLETED NA

Feasibility of Motor-cognitive Home Training for Parkinson's Disease Using eHealth Technology

NCT05027620

Idiopathic Parkinson Disease Telerehabilitation Physical Therapy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This interdisciplinary home visit program consists of 4 visits to patients' homes over the course of one year from a team of a movement disorders doctor, a nurse, a research coordinator, and a social worker. The team will come to a patient's home and assess the needs of both the patient and caregiver, and connect the patient with any needed services. These visits can replace or be in addition to seeing another movement disorders doctor.

As part of this study, not only would the patient receive home visits, but his/her caregiver would be paired with another caregiver from the community with lots of experience caring for someone with PD whose loved one may have passed away, but who volunteers to serve as a mentor. Current caregivers who enroll in the study will be asked to speak to their mentor once a week over a course of 4 months. These meetings can take place in person, by phone, or through video chat on an iPad that will be provided by our study team.

The information collected from the study participants will be compared to data available in the National Parkinson's Foundation's Parkinson's Outcome Project. The data will be matched according to age, gender, and disease severity.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

prospective cohort study (Aims 1 \& 2) stepped wedge trial of caregiver peer mentoring (Aim 3)

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HVP Patient-Subject

Patients will be asked to participate in four study visits, which will involve in-home clinical assessments, a needs assessment, and completion of some questionnaires. Additional information will be obtained from patients' routine medical records: their medical and medication history, family history, neurological examination findings, and office visit records.

Completion of Home Visit Program intervention.

Group Type ACTIVE_COMPARATOR

Home Visit Program

Intervention Type BEHAVIORAL

RC: Informed consent discussion, documentation RN: UPDRS I-II, vitals, medication reconciliation, patient medical history and comorbidities RN and SW: Home safety assessment SW: Psychosocial assessment of dyad, HADS, assessment of mobility and homebound status, needs assessment of dyad, caregiver medical history and comorbidities RC: patient and caregiver short MoCA, PD-Rx, health literacy assessment, satisfaction surveys; patient PDQ-39/PDQ-8

HVP Caregiver-Subject

Caregivers enrolling in the study will be asked to participate in the four home visits, which will involve in-home clinical assessments and completion of some questionnaires. After the first home visit, caregivers will be matched with a peer mentor, an individual who was a prior caregiver to someone with PD who is interested in sharing their knowledge, experience, and time to help improve the lives of current caregivers. Once a week, for a period of 4 months between home visits 2 and 3, caregivers will be asked to meet with their peer mentor, who will be trained to serve as a resource and listening ear, in addition to the medical team.

Completion of Home Visit Program and Caregiver Mentorship Program interventions.

Group Type ACTIVE_COMPARATOR

Home Visit Program

Intervention Type BEHAVIORAL

RC: Informed consent discussion, documentation RN: UPDRS I-II, vitals, medication reconciliation, patient medical history and comorbidities RN and SW: Home safety assessment SW: Psychosocial assessment of dyad, HADS, assessment of mobility and homebound status, needs assessment of dyad, caregiver medical history and comorbidities RC: patient and caregiver short MoCA, PD-Rx, health literacy assessment, satisfaction surveys; patient PDQ-39/PDQ-8

Caregiver Mentorship Program

Intervention Type BEHAVIORAL

Both mentors and mentees will be completing this program:

Mentors will be asked to complete: 1) a Mentor Training - One 5-hour session at Rush University Medical Center; and 2) two 16-week periods of mentoring someone who is currently a caregiver for a patient with Parkinson's Disease

Caregivers mentees will be asked to complete a 16 week mentorship program with their assigned mentor

De-identified Control Subjects

Control subjects will be drawn from the National Parkinson Foundation Parkinson Outcomes Project (POP). Patient-caregiver dyads will be matched on patient gender, age, and HY stage.

Group Type NO_INTERVENTION

No interventions assigned to this group

HVP Peer Mentors

Peer mentors enrolled in this study would be asked to complete a five-hour mentor training program. During this training, caregivers will be asked to complete some questionnaires about their background and caregiving experience. After completion of the mentorship training, peer mentors will be paired with a mentee who is a current caregiver enrolled in the home visit study along with their loved one with Parkinson's. Peer mentors will be asked to speak with their mentee once a week for 16 weeks. After a 16 week break, peer mentors will be paired with a second mentee and will repeat the process for another 16-week-long mentoring session.

Completion of Caregiver Mentorship Program intervention.

Group Type ACTIVE_COMPARATOR

Caregiver Mentorship Program

Intervention Type BEHAVIORAL

Both mentors and mentees will be completing this program:

Mentors will be asked to complete: 1) a Mentor Training - One 5-hour session at Rush University Medical Center; and 2) two 16-week periods of mentoring someone who is currently a caregiver for a patient with Parkinson's Disease

Caregivers mentees will be asked to complete a 16 week mentorship program with their assigned mentor

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Home Visit Program

RC: Informed consent discussion, documentation RN: UPDRS I-II, vitals, medication reconciliation, patient medical history and comorbidities RN and SW: Home safety assessment SW: Psychosocial assessment of dyad, HADS, assessment of mobility and homebound status, needs assessment of dyad, caregiver medical history and comorbidities RC: patient and caregiver short MoCA, PD-Rx, health literacy assessment, satisfaction surveys; patient PDQ-39/PDQ-8

Intervention Type BEHAVIORAL

Caregiver Mentorship Program

Both mentors and mentees will be completing this program:

Mentors will be asked to complete: 1) a Mentor Training - One 5-hour session at Rush University Medical Center; and 2) two 16-week periods of mentoring someone who is currently a caregiver for a patient with Parkinson's Disease

Caregivers mentees will be asked to complete a 16 week mentorship program with their assigned mentor

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

HVP Patient-Subject

* Each subject must be 40 years of age or older. A subject may be of either gender, any race, and any ethnicity.
* Subjects must have a diagnosis of idiopathic Parkinson's Disease (inclusive of Parkinson's Disease Dementia) by a neurologist.
* Subjects will have been seen at least once in the past two years in the outpatient movement disorders clinic at Rush University Medical Center
* Subjects must be rated as HY stage 3-5 at the time of screening via chart review of the most recent clinical visit.
* Subjects must reside within a 60-minute public transit or driving distance of Rush University.
* Subjects must live at home (as defined by an independent dwelling such as an apartment, condominium, or house owned or rented by, or provided to/shared with the subject).
* Subjects must be home-bound according to the Medicare definition: "Leaving your home isn't recommended because of your condition; your condition keeps you from leaving home without help (such as using a wheelchair or walker, needing special transportation, or getting help from another person); leaving home takes a considerable and taxing effort." (http://www.medicare.gov/pubs/pdf/10969.pdf)
* Subjects have one or more of the following criteria, as determined by the referring neurologist: motor or cognitive fluctuations, multi-morbidity, medication mismanagement, cognitive impairment, symptoms of depression and/or anxiety, high risk for hospitalization or hospital readmission, high risk for nursing facility admission, suspected elder abuse, recent history of increased falls in home, caregiver burnout suspected, \>2 cancelled or no-show appointments with the movement disorders providers in the preceding 12 months
* Subjects must have a caregiver willing to participate in the study, as defined by an unpaid individual cohabiting with or spending an average of \>20 hours weekly engaged in care-related tasks related to the subject
* Subjects must either: 1) demonstrate capacity to consent, or 2) pending caregiver capacity assessment and caregiver consent, give assent or not dissent. Excluding individuals with cognitive impairment, dementia, depression, or psychosis would limit the generalizability of this study given the prevalence of each in advanced PD.

HVP Caregiver-Subject

* Each subject must be 30 years of age or older. A subject may be of either gender, any race, and any ethnicity.
* Each subject must be an unpaid individual cohabiting with or spending an average of \>20 hours weekly engaged in care-related tasks related to the patient-subject. The caregiver-subject does not need to be the patient-subject's health care proxy or guardian.
* Each subject must demonstrate capacity to consent.
* Each subject must agree to participation in the nested trial of caregiver peer mentoring as a caregiver mentee
* Each subject must have a working telephone number at which he or she can be reached for check-in calls by the study team throughout the study.

Caregiver Peer Mentor

* Each subject must be 30 years of age or older. A subject may be of either gender, any race, and any ethnicity.
* Each subject must have \>2 years of informal caregiving experience for an individual with PD or a related disorder.
* Each subject must have previously participated in a caregiver support group for PD, participated in a PD educational or outreach event, or given permission to be contacted for research.
* Each subject must be primarily English-speaking.
* Each subject must be willing and able to attend a one-time, five-hour mentor training session at Rush University
* Each subject must commit to two, 16-week blocks of peer mentoring either in person, by telephone, or by video conference on a study-provided iPad, for a minimum of 30 minutes weekly.
* Each subject must have a working telephone number at which he or she can be reached for check-in calls by the study team throughout the study.
* Each subject must be willing and able to attend a monthly, 45-minute supervision group during the two 16-week blocks of peer mentoring, held at Rush University.

De-identified Control Subjects

* Each subject must be 40 years of age or older. A subject may be of either gender, any race, and any ethnicity.
* Each subject must be a community-dwelling individual with idiopathic PD as diagnosed by a neurologist
* Each subject must be enrolled in the NPF POP at a US site.
* Each subject must have \>2 consecutive, annual visits documented within the POP at which the subject is staged as HY 3-5.
* Each subject must have a caregiver participating in the POP at the above visits, as defined by completion of the MCSI.

Exclusion Criteria

* Subjects exhibiting symptoms of a severe psychiatric disorder interfering with their ability to participate in the study, as determined by the referring neurologist, study team member, or PI.
* Subjects who are primarily non-English-speaking.

HVP Patient-Subject

* Subjects with diagnoses of atypical parkinsonism or possible/probable PSP, MSA, CBS,or DLB will be excluded.
* Subjects without an informal caregiver will be excluded.

HVP Caregiver-Subject

* Active psychosis or other severe psychiatric disease
* Terminal illness (life expectancy \<12 months)

Caregiver Peer Mentor

* Active psychosis or other severe psychiatric disease
* Terminal illness (life expectancy \<12 months)

Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes